From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

Precision Medicine Online's 2024 survey shows biomarker test expansion but low clinical trial enrollment and long wait times for advanced therapies.

Q-linea AB (publ) (OMX: QLINEA) today shared a Company and Market update. Key messagesAnticipate total contracts for 30 - 40 ASTar instruments by end-2025; roughly 50% in USAdditional placements of 60 ...